Search Results Heading

MBRLSearchResults

mbrl.module.common.modules.added.book.to.shelf
Title added to your shelf!
View what I already have on My Shelf.
Oops! Something went wrong.
Oops! Something went wrong.
While trying to add the title to your shelf something went wrong :( Kindly try again later!
Are you sure you want to remove the book from the shelf?
Oops! Something went wrong.
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
    Done
    Filters
    Reset
  • Discipline
      Discipline
      Clear All
      Discipline
  • Is Peer Reviewed
      Is Peer Reviewed
      Clear All
      Is Peer Reviewed
  • Item Type
      Item Type
      Clear All
      Item Type
  • Subject
      Subject
      Clear All
      Subject
  • Year
      Year
      Clear All
      From:
      -
      To:
  • More Filters
      More Filters
      Clear All
      More Filters
      Source
    • Language
503 result(s) for "Gupta, Ruchi"
Sort by:
Epidemiology and Burden of Food Allergy
Purpose of ReviewIn recent decades, food allergy has become an increasing concern for families, clinicians, and policymakers. This review aims to summarize what is currently known about the epidemiology and population-level burden of IgE-mediated food allergy, including its effects on quality of life.Recent FindingsPrevalence surveys, healthcare utilization data, and findings from longitudinal cohort studies across the globe indicate that food allergy imposes a growing societal burden. Worryingly, recent data indicate that food allergies may be more prevalent among adult populations than previously acknowledged, with many reported cases of adult-onset allergies.SummaryWhile it remains unclear how much of the current population-level burden of disease results from true, IgE-mediated allergy, as much epidemiological data does not incorporate clinical confirmation of disease prevalence—it is clear that affected individuals suffer impairments in their quality of life and incur substantial economic costs—beyond the physical health burden imposed by anaphylaxis.
Federated Learning and Its Role in the Privacy Preservation of IoT Devices
Federated learning (FL) is a cutting-edge artificial intelligence approach. It is a decentralized problem-solving technique that allows users to train using massive data. Unprocessed information is stored in advanced technology by a secret confidentiality service, which incorporates machine learning (ML) training while removing data connections. As researchers in the field promote ML configurations containing a large amount of private data, systems and infrastructure must be developed to improve the effectiveness of advanced learning systems. This study examines FL in-depth, focusing on application and system platforms, mechanisms, real-world applications, and process contexts. FL creates robust classifiers without requiring information disclosure, resulting in highly secure privacy policies and access control privileges. The article begins with an overview of FL. Then, we examine technical data in FL, enabling innovation, contracts, and software. Compared with other review articles, our goal is to provide a more comprehensive explanation of the best procedure systems and authentic FL software to enable scientists to create the best privacy preservation solutions for IoT devices. We also provide an overview of similar scientific papers and a detailed analysis of the significant difficulties encountered in recent publications. Furthermore, we investigate the benefits and drawbacks of FL and highlight comprehensive distribution scenarios to demonstrate how specific FL models could be implemented to achieve the desired results.
Epidemiology and the Growing Epidemic of Food Allergy in Children and Adults Across the Globe
Purpose of Review Food allergies are immune-mediated, complex disorders, which are the source of increasing health concern worldwide. The goal of this review is to present an updated summary of the food allergy (FA) burden among children and adults across different populations, focusing on research from the past 5 years. Recent Findings FAs impact a growing number of global residents—particularly those residing in higher-income, industrialized regions. Moreover, growing epidemiologic evidence suggests that the population health burden of non-IgE-mediated FAs, such as food protein-induced enterocolitis syndrome, may also be higher than previously reported. Summary FA is a complex trait that impacts infants, children, as well as adults across the globe. The population health burden of both IgE- and non-IgE-mediated FAs is likely to grow in the absence of rapid advances and widespread implementation of effective FA prevention and treatment interventions. Systematic epidemiological research initiatives are needed, both nationally and globally, to better understand and reduce the burden of these allergic diseases.
Racial, Ethnic, and Socioeconomic Differences in Food Allergies in the US
Importance Food allergies affect approximately 8% of children and 11% of adults in the US. Racial differences in food allergy outcomes have previously been explored among Black and White children, but little is known about the distribution of food allergies across other racial, ethnic, and socioeconomic subpopulations. Objective To estimate the national distribution of food allergies across racial, ethnic, and socioeconomic groups in the US. Design, Setting, and Participants In this cross-sectional survey study, conducted from October 9, 2015, to September 18, 2016, a population-based survey was administered online and via telephone. A US nationally representative sample was surveyed. Participants were recruited using both probability- and nonprobability-based survey panels. Statistical analysis was performed from September 1, 2022, through April 10, 2023. Exposures Demographic and food allergy–related participant characteristics. Main Outcomes and Measures Stringent symptom criteria were developed to distinguish respondents with a “convincing” food allergy from those with similar symptom presentations (ie, food intolerance or oral allergy syndrome), with or without physician diagnosis. The prevalence of food allergies and their clinical outcomes, such as emergency department visits, epinephrine autoinjector use, and severe reactions, were measured across race (Asian, Black, White, and >1 race or other race), ethnicity (Hispanic and non-Hispanic), and household income. Complex survey-weighted proportions were used to estimate prevalence rates. Results The survey was administered to 51 819 households comprising 78 851 individuals (40 443 adults and parents of 38 408 children; 51.1% women [95% CI, 50.5%-51.6%]; mean [SD] age of adults, 46.8 [24.0] years; mean [SD] age of children, 8.7 [5.2] years): 3.7% Asian individuals, 12.0% Black individuals, 17.4% Hispanic individuals, 62.2% White individuals, and 4.7% individuals of more than 1 race or other race. Non-Hispanic White individuals across all ages had the lowest rate of self-reported or parent-reported food allergies (9.5% [95% CI, 9.2%-9.9%]) compared with Asian (10.5% [95% CI, 9.1%-12.0%]), Hispanic (10.6% [95% CI, 9.7%-11.5%]), and non-Hispanic Black (10.6% [95% CI, 9.8%-11.5%]) individuals. The prevalence of common food allergens varied by race and ethnicity. Non-Hispanic Black individuals were most likely to report allergies to multiple foods (50.6% [95% CI, 46.1%-55.1%]). Asian and non-Hispanic White individuals had the lowest rates of severe food allergy reactions (Asian individuals, 46.9% [95% CI, 39.8%-54.1%] and non-Hispanic White individuals, 47.8% [95% CI, 45.9%-49.7%]) compared with individuals of other races and ethnicities. The prevalence of self-reported or parent-reported food allergies was lowest within households earning more than $150 000 per year (8.3% [95% CI, 7.4%-9.2%]). Conclusions and Relevance This survey study of a US nationally representative sample suggests that the prevalence of food allergies was highest among Asian, Hispanic, and non-Hispanic Black individuals compared with non-Hispanic White individuals in the US. Further assessment of socioeconomic factors and corresponding environmental exposures may better explain the causes of food allergy and inform targeted management and interventions to reduce the burden of food allergies and disparities in outcomes.
Prevalence and Severity of Food Allergies Among US Adults
Food allergy is a costly, potentially life-threatening condition. Although studies have examined the prevalence of childhood food allergy, little is known about prevalence, severity, or health care utilization related to food allergies among US adults. To provide nationally representative estimates of the distribution, severity, and factors associated with adult food allergies. In this cross-sectional survey study of US adults, surveys were administered via the internet and telephone from October 9, 2015, to September 18, 2016. Participants were first recruited from NORC at the University of Chicago's probability-based AmeriSpeak panel, and additional participants were recruited from the non-probability-based Survey Sampling International (SSI) panel. Demographic and allergic participant characteristics. Self-reported food allergies were the main outcome and were considered convincing if reported symptoms to specific allergens were consistent with IgE-mediated reactions. Diagnosis history to specific allergens and food allergy-related health care use were also primary outcomes. Estimates were based on this nationally representative sample using small-area estimation and iterative proportional fitting methods. To increase precision, AmeriSpeak data were augmented by calibration-weighted, non-probability-based responses from SSI. Surveys were completed by 40 443 adults (mean [SD] age, 46.6 [20.2] years), with a survey completion rate of 51.2% observed among AmeriSpeak panelists (n = 7210) and 5.5% among SSI panelists (n = 33 233). Estimated convincing food allergy prevalence among US adults was 10.8% (95% CI, 10.4%-11.1%), although 19.0% (95% CI, 18.5%-19.5%) of adults self-reported a food allergy. The most common allergies were shellfish (2.9%; 95% CI, 2.7%-3.1%), milk (1.9%; 95% CI, 1.8%-2.1%), peanut (1.8%; 95% CI, 1.7%-1.9%), tree nut (1.2%; 95% CI, 1.1%-1.3%), and fin fish (0.9%; 95% CI, 0.8%-1.0%). Among food-allergic adults, 51.1% (95% CI, 49.3%-52.9%) experienced a severe food allergy reaction, 45.3% (95% CI, 43.6%-47.1%) were allergic to multiple foods, and 48.0% (95% CI, 46.2%-49.7%) developed food allergies as an adult. Regarding health care utilization, 24.0% (95% CI, 22.6%-25.4%) reported a current epinephrine prescription, and 38.3% (95% CI, 36.7%-40.0%) reported at least 1 food allergy-related lifetime emergency department visit. These data suggest that at least 10.8% (>26 million) of US adults are food allergic, whereas nearly 19% of adults believe that they have a food allergy. Consequently, these findings suggest that it is crucial that adults with suspected food allergy receive appropriate confirmatory testing and counseling to ensure food is not unnecessarily avoided and quality of life is not unduly impaired.
An Optofluidic Young Interferometer for Electrokinetic Transport-Coupled Biosensing
Label-free optical biosensors, such as interferometers, can provide a comparable limit of detection to widely used enzyme-linked immunosorbent assays while minimizing the number of steps and reducing false positives/negatives. In 2020, the authors reported on a novel optofluidic Young interferometer (YI) that could provide real-time spatial information on refractive index changes occurring along the length of the sensor and reference channels. Herein, we exploit these features of the YI to study interactions of biomolecules with recognition elements immobilized in selected regions of agarose gel in the sensor channel. We show that the YI is well suited for the biosensing of an exemplar biomolecule, streptavidin, in the absence and presence of the bovine serum albumin interferent. Equally, we couple the YI with electrokinetic transport to reduce the time needed for biosensing.
Effect of access to finance and investment climate on the performance of small and medium enterprises (SMEs) in India
Small and medium-sized enterprises (SMEs) are crucial for economic development and achieving developmental goals in developing economies. However, they face challenges related to access to finance and the investment climate. This study investigates how access to finance and the investment climate affect SME performance, using data from the World Bank Enterprise Survey (2022) covering 6,383 SMEs in India. The study uses four performance indicators: employment growth, annual sales growth, capacity utilization, and labour productivity growth. The two-stage least squares (2SLS) method is applied to address potential endogeneity, and post-estimation tests such as the Cragg-Donald F-statistic, the Sargan test, and the Basmann test are used to assess the validity of the instrument. The study’s major findings suggest that access to formal working capital finance positively affects firm performance, whereas access to formal fixed-asset finance negatively affects it. Additionally, mixed evidence is found regarding the effect of access to informal finance on firm performance. The effect of investment climate variables, particularly informal competition, negatively impacts firm performance, while the impact of other variables remains inconclusive. Moreover, it is observed that firm performance decreases with firm size. The study’s findings introduce nuanced insights into formal finance and informal competition, providing an in-depth look at how these unique factors shape SME growth in developing economies. Therefore, to support SMEs in India, policies should aim to improve access to working capital through flexible and affordable financing options, and measures should be taken to reduce informal competition.
Genome-wide association study identifies peanut allergy-specific loci and evidence of epigenetic mediation in US children
Food allergy (FA) affects 2%–10% of US children and is a growing clinical and public health problem. Here we conduct the first genome-wide association study of well-defined FA, including specific subtypes (peanut, milk and egg) in 2,759 US participants (1,315 children and 1,444 parents) from the Chicago Food Allergy Study, and identify peanut allergy (PA)-specific loci in the HLA-DR and -DQ gene region at 6p21.32, tagged by rs7192 ( P =5.5 × 10 −8 ) and rs9275596 ( P =6.8 × 10 −10 ), in 2,197 participants of European ancestry. We replicate these associations in an independent sample of European ancestry. These associations are further supported by meta-analyses across the discovery and replication samples. Both single-nucleotide polymorphisms (SNPs) are associated with differential DNA methylation levels at multiple CpG sites ( P <5 × 10 −8 ), and differential DNA methylation of the HLA-DQB1 and HLA-DRB1 genes partially mediate the identified SNP–PA associations. This study suggests that the HLA-DR and - DQ gene region probably poses significant genetic risk for PA. Food allergy is a growing clinical and public health burden. Here, the authors carry out a genome-wide association study in samples with well-defined allergies to a variety of foods, and identify the 6p21.32 region that significantly increases risk of developing peanut allergy.
Geographic Variability of Medicaid Acceptance Among Allergists in the US
To determine the geographic variability of Medicaid acceptance among allergists in the US. Geospatial analysis predicted Medicaid acceptance across space, and a multivariable regression identified area-level population demographic variables associated with acceptance. We used the National Plan & Provider Enumeration System database to identify allergists. Medicaid acceptance was determined from lists or search engines from state Medicaid offices and calls to provider offices. Spatial analysis was performed using the empirical Bayesian kriging tool. Multivariate logistic regression was used to identify county-level characteristics associated with provider Medicaid acceptance. Of 5694 allergists, 55.5% accepted Medicaid. Acceptance in each state ranged from 13% to 90%. Washington, Arizona, and the Northeast had lowest predicted proportion of both Medicaid acceptance and Medicaid acceptance per 10,000 enrollees. Overall, county-level characteristics were not associated with the likelihood of accepting Medicaid in multivariate analyses. Only the percentage of individuals living in poverty was associated with a higher likelihood of providers accepting Medicaid (OR, 1.245; 95% CI, 1.156-1.340; P < .001). A barrier to accessing allergy-related health care is finding a provider who accepts a patient's insurance, which is largely variable by state. Lack of access to allergy care likely affects health outcomes for children with prevalent atopic conditions such as food allergy.
Trends in the Use of Intracytoplasmic Sperm Injection in the United States
In vitro fertilization (IVF) with intracytoplasmic sperm injection (ICSI) is effective for male-factor infertility; its role for other forms of infertility is unclear. ICSI is more costly than IVF alone and may confer more risks. In the United States from 1995 to 2004, the use of ICSI increased dramatically, while diagnoses of male-factor infertility remained stable. These data suggest that guidance regarding the appropriate use of ICSI is warranted. In the United States from 1995 to 2004, the use of ICSI increased dramatically, while diagnoses of male-factor infertility remained stable. These data suggest that guidance regarding the appropriate use of ICSI is warranted. The introduction of in vitro fertilization (IVF) in 1978 1 led to advances in treatment for infertility. 2 However, effective treatment for male-factor infertility (determined on the basis of abnormal semen measurements) was not available until 1992, when intracytoplasmic sperm injection (ICSI) was introduced as part of the IVF process in selected cases. 3 In 1994, the American Society for Reproductive Medicine published guidelines regarding the use of ICSI as a safe and effective technique for the management of male-factor infertility. 4 However, with the increasing availability and use of assisted reproductive technology, it is unclear to what extent fertility centers in the United . . .